SynthesisPloS one2022
Cost-effectiveness of PARP inhibitors in malignancies: A systematic review.
Haiying Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
SynthesisPloS one2022
Haiying Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.